Ministry of Health | Saudi Arabia
Dr. Mariam Tarkistani is an accomplished biomedical scientist and visionary leader in immunology, nanotechnology, and clinical innovation, currently serving as Head of Immunology and Serology at King Faisal Hospital in Makkah, where she leads strategic advancements in clinical diagnostics, immunotherapeutic research, and laboratory excellence. With a strong academic foundation in biomedical science, biotechnology, and laboratory medicine, and a doctoral specialization in nano-drug delivery for cancer targeting and T-cell modulation, she has established herself as a pioneering researcher whose work bridges the fields of oncology, immunotherapy, and nanomedicine. Dr. Tarkistani’s research focuses on metal nanoparticles, bispecific antibodies, nanoparticle-mediated immune stimulation, and innovative therapeutic systems for cancer and antimicrobial resistance, contributing significantly to modern healthcare solutions and precision medicine. Her scientific achievements have gained international recognition, demonstrated through major global awards for innovation, including distinctions for groundbreaking biotechnology applications and impactful scientific contributions. She is a respected author in high-impact research domains, accumulating 86 citations, supported by an h-index of 2 and an i10-index of 2, reflecting the growing influence of her published work and its relevance to emerging biomedical technologies. Beyond research, she has led transformative initiatives as Director of Innovation, supporting intellectual property development, promoting research commercialization, and mentoring teams across multidisciplinary medical and scientific sectors. Her leadership roles include expertise in clinical consultation for complex immunological cases, laboratory operations optimization, and advanced diagnostic methodologies that elevate patient care standards. Dr. Tarkistani actively engages in scientific dissemination through keynote speaking, conference presentations, and peer-review contributions to notable international journals. Her commitment to innovation is further strengthened by multiple granted and pending patents, spanning laboratory instrumentation, nanoparticle engineering, and therapeutic biotechnology. A dedicated advocate for scientific progress and women in STEM, Dr. Tarkistani continues to inspire breakthrough discoveries that shape the future of global healthcare.
Featured Publications
Tarkistani, M. A. M., Komalla, V., & Kayser, V. (2021). Recent advances in the use of iron–gold hybrid nanoparticles for biomedical applications. Nanomaterials, 11(5), 1227.
Anisuzzman, M., Komalla, V., Tarkistani, M. A. M., & Kayser, V. (2023). Anti-tumor activity of novel nimotuzumab-functionalized gold nanoparticles as a potential immunotherapeutic agent against skin and lung cancers. Journal of Functional Biomaterials, 14(8), 407.
Tarkistani, M. A. M., Komalla, V., & Kayser, V. (2021). Recent advances in the use of iron–gold hybrid nanoparticles for biomedical applications. Nanomaterials, 11(5), 1227.
Tarkistani, M. A. M., Komalla, V., & Kayser, V. (n.d.). Iron-gold nano-delivery approaches for cancer cell targeting and T-cell redirecting.